Hora Amoozegar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hora Amoozegar has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Mehrangiz Ghafari
Department of Pathology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran
2 shared publications - Ahmad Mir Hosseini
Medical doctor, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Asghar Rahmani
Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Asma Sobhani
Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
1 shared publication - Atefeh Rahimi
Department of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication - Atefehsadat Monirvaghefi
Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States
1 shared publication
Latest Publications
- 11 September 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1) , 214
Neuroprotective impact of nicotinamide riboside and metformin on the hippocampus of male rats with diet-induced obesity
Background: Obesity-induced metabolic disturbances are increasingly recognized as major contributors to hippocampal dysfunction and neurodegeneration. Chronic exposure to a high-fat diet (HFD) has been associated with hippocampal structural alterations, dysregulation of neurotrophic and metabolic signalling, and increased neuronal vulnerability, ultimately impairing cognitive performance. Objective: This study investigated the neuroprotective effects of nicotinamide riboside (NR), metformin (MET), and their combination on hippocampal structure, gene expression, and spatial memory in a male rat model of diet-induced obesity. Methods: Male Wistar rats were assigned to a lean control group or a high-fat diet (HFD) group and maintained on their respective diets for 10 weeks. During the final 4 weeks of the HFD protocol, HFD-fed rats received nicotinamide riboside (NR; 300 mg/kg/day), metformin (MET; 200 mg/kg/day), or their combination by oral gavage while continuing HFD feeding. Stereological analysis was performed to assess hippocampal subregion volumes (CA1 and dentate gyrus), neuronal survival, and total glial cell counts based on morphological criteria. Gene expression levels of Bdnf, Sirt1, Ppargc1a, Bax, Bcl-2, and Casp3 were measured using quantitative real-time PCR (qRT-PCR). Spatial learning and memory were evaluated using the Morris Water Maze (MWM) test. Results: HFD feeding induced obesity accompanied by hippocampal atrophy, altered expression of neurotrophic, metabolic, and apoptosis-related genes, and impaired spatial memory. Treatment with NR and MET, particularly in combination, was associated with attenuation of these alterations. The combination treatment showed the greatest improvement in hippocampal volume, greater neuronal preservation, reduced morphologically identified glial cell counts, and partial normalization of gene expression patterns. Behavioral analysis also indicated better performance in spatial learning and memory, with the NR + MET group showing the most pronounced improvement in escape latency and time spent in the target quadrant. Conclusion: NR and metformin were associated with beneficial effects on obesity-related hippocampal alterations, accompanied by favourable changes in apoptosis-related, metabolic, and neurotrophic gene expression as well as improved stereological indices of hippocampal integrity. The combined treatment generally produced greater improvements than either monotherapy. These findings support further investigation of NR and metformin as potential interventions for obesity-associated hippocampal dysfunction and cognitive impairment. Graphical Abstract A high-fat diet induces hippocampal structural damage, increased glial cell profiles, and neuronal loss, leading to impaired spatial cognitive function. Treatment with nicotinamide riboside (NR) and metformin (MET), particularly in combination, mitigates hippocampal pathology by improving mitochondrial-related signaling and reducing apoptotic processes, resulting in preserved hippocampal structure and improved spatial memory
- 11 September 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1) , 214
Neuroprotective impact of nicotinamide riboside and metformin on the hippocampus of male rats with diet-induced obesity
Background: Obesity-induced metabolic disturbances are increasingly recognized as major contributors to hippocampal dysfunction and neurodegeneration. Chronic exposure to a high-fat diet (HFD) has been associated with hippocampal structural alterations, dysregulation of neurotrophic and metabolic signalling, and increased neuronal vulnerability, ultimately impairing cognitive performance. Objective: This study investigated the neuroprotective effects of nicotinamide riboside (NR), metformin (MET), and their combination on hippocampal structure, gene expression, and spatial memory in a male rat model of diet-induced obesity. Methods: Male Wistar rats were assigned to a lean control group or a high-fat diet (HFD) group and maintained on their respective diets for 10 weeks. During the final 4 weeks of the HFD protocol, HFD-fed rats received nicotinamide riboside (NR; 300 mg/kg/day), metformin (MET; 200 mg/kg/day), or their combination by oral gavage while continuing HFD feeding. Stereological analysis was performed to assess hippocampal subregion volumes (CA1 and dentate gyrus), neuronal survival, and total glial cell counts based on morphological criteria. Gene expression levels of Bdnf, Sirt1, Ppargc1a, Bax, Bcl-2, and Casp3 were measured using quantitative real-time PCR (qRT-PCR). Spatial learning and memory were evaluated using the Morris Water Maze (MWM) test. Results: HFD feeding induced obesity accompanied by hippocampal atrophy, altered expression of neurotrophic, metabolic, and apoptosis-related genes, and impaired spatial memory. Treatment with NR and MET, particularly in combination, was associated with attenuation of these alterations. The combination treatment showed the greatest improvement in hippocampal volume, greater neuronal preservation, reduced morphologically identified glial cell counts, and partial normalization of gene expression patterns. Behavioral analysis also indicated better performance in spatial learning and memory, with the NR + MET group showing the most pronounced improvement in escape latency and time spent in the target quadrant. Conclusion: NR and metformin were associated with beneficial effects on obesity-related hippocampal alterations, accompanied by favourable changes in apoptosis-related, metabolic, and neurotrophic gene expression as well as improved stereological indices of hippocampal integrity. The combined treatment generally produced greater improvements than either monotherapy. These findings support further investigation of NR and metformin as potential interventions for obesity-associated hippocampal dysfunction and cognitive impairment. Graphical Abstract A high-fat diet induces hippocampal structural damage, increased glial cell profiles, and neuronal loss, leading to impaired spatial cognitive function. Treatment with nicotinamide riboside (NR) and metformin (MET), particularly in combination, mitigates hippocampal pathology by improving mitochondrial-related signaling and reducing apoptotic processes, resulting in preserved hippocampal structure and improved spatial memory
- Open Access
- 21 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Bifidobacterium adolescentis attenuates cardiac remodeling in HFD/STZ-induced obesity-associated diabetic cardiomyopathy
Obesity-associated diabetic cardiomyopathy is characterized by cardiac structural remodeling and modification of gene expression. Increasing evidence has led to the conclusion that gut microbiota, particularly probiotics, may modulate cardiac health through systemic and molecular pathways. The aim of the current study was to explore the cardioprotective effects of Bifidobacterium adolescentis on cardiac structure and gene expression in a rat model of high-fat diet (HFD) and low-dose streptozotocin (STZ)-induced obesity-associated diabetic cardiomyopathy. Male Wistar rats were divided into the following four groups: control, HFD, HFD- B. adolescentis (8 weeks), and HFD-B. adolescentis (16 weeks). Stereological studies were conducted to quantify left ventricular and myocardial volume. Real-time PCR was used to quantify the levels of genes associated with cardiac stress, fibrosis, inflammation, and contractility, like ANP, BNP, TGF-β, GATA4, Myc, Nfkb1, NPR1, Kcnq1, MEF2D, and SERCA2a. HFD/STZ treatment significantly increased heart weight (+ 68%) and left ventricular volume (+ 63%), elevated myocardial volume (+ 42%), and reduced vascular volume. Hypertrophic and inflammatory genes (ANP, BNP, TGF-β, GATA4, Myc, Nfkb1) were markedly upregulated, while contractility-related genes (MEF2D, SERCA2a, NPR1, KCNQ1) were downregulated. B. adolescentis supplementation for 8–16 weeks reversed these alterations, normalizing structural indices and restoring gene expression toward control levels. Bifidobacterium adolescentis attenuated obesity- and hyperglycemia-associated cardiac remodeling by improving structural and molecular parameters. These findings identify B. adolescentis as a potential probiotic candidate for preventing obesity-associated diabetic cardiomyopathy.
- 21 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessBifidobacterium adolescentis attenuates cardiac remodeling in HFD/STZ-induced obesity-associated diabetic cardiomyopathy
Obesity-associated diabetic cardiomyopathy is characterized by cardiac structural remodeling and modification of gene expression. Increasing evidence has led to the conclusion that gut microbiota, particularly probiotics, may modulate cardiac health through systemic and molecular pathways. The aim of the current study was to explore the cardioprotective effects of Bifidobacterium adolescentis on cardiac structure and gene expression in a rat model of high-fat diet (HFD) and low-dose streptozotocin (STZ)-induced obesity-associated diabetic cardiomyopathy. Male Wistar rats were divided into the following four groups: control, HFD, HFD- B. adolescentis (8 weeks), and HFD-B. adolescentis (16 weeks). Stereological studies were conducted to quantify left ventricular and myocardial volume. Real-time PCR was used to quantify the levels of genes associated with cardiac stress, fibrosis, inflammation, and contractility, like ANP, BNP, TGF-β, GATA4, Myc, Nfkb1, NPR1, Kcnq1, MEF2D, and SERCA2a. HFD/STZ treatment significantly increased heart weight (+ 68%) and left ventricular volume (+ 63%), elevated myocardial volume (+ 42%), and reduced vascular volume. Hypertrophic and inflammatory genes (ANP, BNP, TGF-β, GATA4, Myc, Nfkb1) were markedly upregulated, while contractility-related genes (MEF2D, SERCA2a, NPR1, KCNQ1) were downregulated. B. adolescentis supplementation for 8–16 weeks reversed these alterations, normalizing structural indices and restoring gene expression toward control levels. Bifidobacterium adolescentis attenuated obesity- and hyperglycemia-associated cardiac remodeling by improving structural and molecular parameters. These findings identify B. adolescentis as a potential probiotic candidate for preventing obesity-associated diabetic cardiomyopathy.
- 19 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 337-344
Mapping Epileptic Networks: IED-Triggered Hemodynamic Changes Identified via Simultaneous EEG-fMRI Recordings
A central goal of the presurgical evaluation for refractory focal epilepsy is the accurate delineation of the epileptogenic zone (EZ)-the cortical region indispensable for generating epileptic seizures. Given that electroencephalography (EEG) provides superior temporal resolution while functional magnetic resonance imaging (fMRI) offers enhanced spatial localization, integrating these modalities holds significant promise for improving epileptic focus identification. In this study, we first derived characteristic spike patterns by detecting and averaging interictal epileptiform discharges (IEDs) from extraoperative EEG recordings. These patterns were then correlated with intracranial EEG data to develop an automated system for precise temporal mapping of seizure activity. Finally, we convolved the resulting temporal regressor with the hemodynamic response function (HRF) within a general linear model (GLM) framework to achieve robust localization of epileptic foci. This study was performed on five medication-resistant epilepsy patients whose neuroimaging and electrophysiological data were acquired at the National Brain Mapping Lab (NBML). Our proposed methodology demonstrated strong concordance with clinical EEG findings across all five cases. Notably, for the three surgical candidates, the approach provided additional localizing information beyond conventional EEG data. Quantitative analysis revealed statistically significant enhancements in both localization accuracy ($\mathbf{p}<0.05$) and spatial precision (mean ± SEM: $2.3 \pm 0.4 \text{mm}$) compared to current gold-standard techniques reported in recent literature.
- 19 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 337-344
Mapping Epileptic Networks: IED-Triggered Hemodynamic Changes Identified via Simultaneous EEG-fMRI Recordings
A central goal of the presurgical evaluation for refractory focal epilepsy is the accurate delineation of the epileptogenic zone (EZ)-the cortical region indispensable for generating epileptic seizures. Given that electroencephalography (EEG) provides superior temporal resolution while functional magnetic resonance imaging (fMRI) offers enhanced spatial localization, integrating these modalities holds significant promise for improving epileptic focus identification. In this study, we first derived characteristic spike patterns by detecting and averaging interictal epileptiform discharges (IEDs) from extraoperative EEG recordings. These patterns were then correlated with intracranial EEG data to develop an automated system for precise temporal mapping of seizure activity. Finally, we convolved the resulting temporal regressor with the hemodynamic response function (HRF) within a general linear model (GLM) framework to achieve robust localization of epileptic foci. This study was performed on five medication-resistant epilepsy patients whose neuroimaging and electrophysiological data were acquired at the National Brain Mapping Lab (NBML). Our proposed methodology demonstrated strong concordance with clinical EEG findings across all five cases. Notably, for the three surgical candidates, the approach provided additional localizing information beyond conventional EEG data. Quantitative analysis revealed statistically significant enhancements in both localization accuracy ($\mathbf{p}<0.05$) and spatial precision (mean ± SEM: $2.3 \pm 0.4 \text{mm}$) compared to current gold-standard techniques reported in recent literature.
- Open Access
- 25 December 2023
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 2 (4) , 65-74
Application of Nanobiosensors in Detection of Pathogenic Bacteria: An Update
Bacterial infections remain a critical public health concern worldwide, necessitating the development of efficient and sensitive diagnostic tools. Nanobiosensors, comprising nanomaterials, offer a novel approach to bacterial pathogen detection. The present review aimed to explore the current research and applications of nanobiosensors for bacterial pathogen detection. Recent discoveries in nanotechnology have facilitated the development of nanobiosensors with remarkable sensitivity and specificity. These nanoscale sensors are designed to detect specific bacterial pathogens through various mechanisms, including aptamers, antibodies, and molecular recognition elements. Furthermore, miniaturization and integration with microfluidic systems have enabled the rapid and point-of-care detection of bacterial infections. Incorporating nanomaterials such as carbon nanotubes, quantum dots, and graphene into biosensing platforms has significantly enhanced their performance, leading to ultrasensitive detection of bacterial antigens and nucleic acids. Additionally, using nanobiosensors with advanced analytical techniques, such as electrochemical, optical, and piezoelectric methods, has expanded the possibilities for accurate and real-time monitoring of bacterial pathogens. Nanobiosensors represent a promising frontier in the battle against bacterial infections. Their exceptional sensitivity, rapid response times, and potential for multiplexed detection make them invaluable tools for the early diagnosis and monitoring of bacterial pathogens. Developing cost-effective and portable nanobiosensors for resource-limited settings becomes increasingly possible as nanotechnology advances.
- 25 December 2023
- Published by Rovedar in Research in Biotechnology and Environmental Science
- Vol. 2 (4) , 65-74
Open AccessApplication of Nanobiosensors in Detection of Pathogenic Bacteria: An Update
Bacterial infections remain a critical public health concern worldwide, necessitating the development of efficient and sensitive diagnostic tools. Nanobiosensors, comprising nanomaterials, offer a novel approach to bacterial pathogen detection. The present review aimed to explore the current research and applications of nanobiosensors for bacterial pathogen detection. Recent discoveries in nanotechnology have facilitated the development of nanobiosensors with remarkable sensitivity and specificity. These nanoscale sensors are designed to detect specific bacterial pathogens through various mechanisms, including aptamers, antibodies, and molecular recognition elements. Furthermore, miniaturization and integration with microfluidic systems have enabled the rapid and point-of-care detection of bacterial infections. Incorporating nanomaterials such as carbon nanotubes, quantum dots, and graphene into biosensing platforms has significantly enhanced their performance, leading to ultrasensitive detection of bacterial antigens and nucleic acids. Additionally, using nanobiosensors with advanced analytical techniques, such as electrochemical, optical, and piezoelectric methods, has expanded the possibilities for accurate and real-time monitoring of bacterial pathogens. Nanobiosensors represent a promising frontier in the battle against bacterial infections. Their exceptional sensitivity, rapid response times, and potential for multiplexed detection make them invaluable tools for the early diagnosis and monitoring of bacterial pathogens. Developing cost-effective and portable nanobiosensors for resource-limited settings becomes increasingly possible as nanotechnology advances.